deferoxamine has been researched along with clioquinol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bush, AI; Cahill, CM; Eder, PS; Giordano, T; Greig, NH; Gullans, SR; Gunshin, H; Huang, X; Lahiri, DK; Leiter, L; McPhee, J; Randall, JD; Rogers, JT; Sarang, SS; Tanzi, RE; Utsuki, T | 1 |
| Bush, AI; Doraiswamy, PM; Finefrock, AE | 1 |
| Bandyopadhyay, S; Cho, H; Greig, NH; Huang, X; Rogers, JT; Youdim, MB | 1 |
| Drever, BD; Nday, CM; Platt, B; Salifoglou, T | 1 |
| Bester, J; Gericke, GS; Kell, DB; Lipinski, B; Pretorius, E; Vermeulen, N | 1 |
| Cilliers, K | 1 |
2 review(s) available for deferoxamine and clioquinol
| Article | Year |
|---|---|
Current status of metals as therapeutic targets in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Chelating Agents; Clioquinol; Copper; Deferoxamine; Diet; Humans; Iron; Zinc | 2003 |
Trace element alterations in Alzheimer's disease: A review.
Topics: Alzheimer Disease; Clioquinol; Copper; Deferoxamine; Humans; Metals; Penicillamine; Siderophores; Trace Elements | 2021 |
5 other study(ies) available for deferoxamine and clioquinol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.
Topics: 5' Untranslated Regions; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Base Sequence; Calcium; Clioquinol; Deferoxamine; Enhancer Elements, Genetic; Gene Expression Regulation; Genes, Reporter; Humans; Interleukin-1; Iron; Iron Chelating Agents; Magnesium; Mice; Molecular Sequence Data; Nucleic Acid Conformation; Protein Biosynthesis; Response Elements; RNA, Messenger; Tumor Cells, Cultured | 2002 |
Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator.
Topics: Amyloid beta-Protein Precursor; Cell Line, Tumor; Clioquinol; Deferoxamine; Dose-Response Relationship, Drug; Glioblastoma; Humans; Iron Chelating Agents; Iron-Regulatory Proteins; Models, Molecular; Neuroblastoma; Protein Biosynthesis; RNA, Messenger; Transfection; Untranslated Regions | 2006 |
Aluminum does not enhance beta-amyloid toxicity in rat hippocampal cultures.
Topics: Aluminum; Amyloid beta-Peptides; Animals; Cell Death; Cell Survival; Chelating Agents; Clioquinol; Deferoxamine; Drug Synergism; Hippocampus; Neuroglia; Neurons; Quinic Acid; Rats | 2010 |
Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.
Topics: Adolescent; Adult; Child; Clioquinol; Deferoxamine; Erythrocytes; Female; Ferritins; Fibrin; Hemochromatosis; Humans; Hydroxyl Radical; Iron; Iron Chelating Agents; Male; Microscopy, Electron, Scanning; Middle Aged; Platelet-Rich Plasma; Salicylic Acid; Selenious Acid; Thrombin; Up-Regulation | 2014 |